NCT01777802View on ClinicalTrials.gov

Immune Responses in Prostate, Lung, Melanoma and Breast Cancer Patients Following Stereotactic Body Radiotherapy (SBRT), Intensity Modulated Radiotherapy (IMRT) or Brachytherapy

CompletedOBSERVATIONAL
Enrollment

98

Participants

Timeline

Start Date

January 2, 2013

Primary Completion Date

June 21, 2023

Study Completion Date

June 21, 2023

Conditions
Prostate CancerBreast CancerLung CancerMelanoma
Interventions
RADIATION

SBRT

RADIATION

IMRT

RADIATION

Brachytherapy

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT01777802 - Immune Responses in Prostate, Lung, Melanoma and Breast Cancer Patients Following Stereotactic Body Radiotherapy (SBRT), Intensity Modulated Radiotherapy (IMRT) or Brachytherapy | Biotech Hunter | Biotech Hunter